Optic chiasmal herniation - An under recognized complication of dopamine agonist therapy for macroprolactinoma

Clinical Endocrinology

Volumn 53, Issue 4, 2000, Pages 529-534

  Jones, S E ^a,b   James, R A ^a   Hall, K ^a   Kendall Taylor, P ^a  

^a ROYAL VICTORIA INFIRMARY   (United Kingdom)

^b FREEMAN HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BROMOCRIPTINE; CABERGOLINE; DOPAMINE RECEPTOR STIMULATING AGENT; PROLACTIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; DOSE RESPONSE; FEMALE; HEMIANOPIA; HERNIA; HUMAN; HYPERPROLACTINEMIA; HYPOPHYSIS APOPLEXY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC CHIASM; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROLACTINOMA; TREATMENT PLANNING; VISUAL FIELD DEFECT; VISUAL IMPAIRMENT;

ADULT; BROMOCRIPTINE; DOPAMINE AGONISTS; DRUG ADMINISTRATION SCHEDULE; HERNIA; HUMANS; MALE; MIDDLE AGED; OPTIC CHIASM; PITUITARY NEOPLASMS; PROLACTIN; PROLACTINOMA; VISION DISORDERS; VISUAL ACUITY;

EID: 0033785896     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.2000.01039.x     Document Type: Article

References (16)

1. CSF rhinnorhea after bromocriptine for prolactinoma
2. Long-term and low-dose treatment with cabergoline induces macroprolactinoma shrinkage
3. Transphenoidal chiasmapexy for correction of post-hypophysectomy traction syndrome of the optic chiasm
4. Reversible visual field defect following debulking of a Ranthke's cleft cyst: Tethered chiasm
5. The chiasmal traction syndrome
6. Herniation of the suprasellar visual system and the third ventricle into empty sellae: Morphological and clinical considerations
7. Macroprolactinomas: Serial MR imaging in long-term bromocriptine therapy
8. Rapid resolution of visual field abnormalities with medical therapy alone in patients with large prolactinomas
9. Reduction in size of a pituitary tumour by bromocriptine therapy
10. Age-related and gender-related occurence of pituitary adenomas
11. Bromocriptine as a primary therapy for prolactin secreting macroadenoma: Results of a prospective multicenter study
12. A study of the clinical differences between women and men with hyperprolatinaemia
13. Chiasmal herniation as a complication of bromocriptine therapy
14. Quinagolide efficacy and tolerability in hyperprolactinaemic patients who are resistant to or intolerant of bromocriptine
15. The efficacy and tolerablity of long term cabergoline therapy in hyperprolactinaemic disorders: An open, uncontrolled, multicentre study. European Multicentre Cabergoline Study Group
16. Chiasmapexy for the correction of traction of the optic nerves and chiasm associated with their descent into an empty sella turcica. Case report